Legal & General Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.4M | Buy |
1,411,199
+1,200,200
| +569% | +$9.32M | ﹤0.01% | 986 |
|
|
2025
Q4 | $1.65M | Sell |
210,999
-15,166
| -7% | -$110K | ﹤0.01% | 2049 |
|
|
2025
Q3 | $1.72M | Sell |
226,165
-978,318
| -81% | -$8.15M | ﹤0.01% | 2043 |
|
|
2025
Q2 | $10.8M | Buy |
1,204,483
+223,265
| +23% | +$2.08M | ﹤0.01% | 1140 |
|
|
2025
Q1 | $7.36M | Buy |
981,218
+706,135
| +257% | +$5.7M | ﹤0.01% | 1307 |
|
|
2024
Q4 | $2.07M | Buy |
275,083
+25,338
| +10% | +$192K | ﹤0.01% | 1966 |
|
|
2024
Q3 | $1.9M | Sell |
249,745
-16,528
| -6% | -$126K | ﹤0.01% | 1997 |
|
|
2024
Q2 | $1.65M | Sell |
266,273
-10,418
| -4% | -$57.5K | ﹤0.01% | 2028 |
|
|
2024
Q1 | $1.41M | Sell |
276,691
-32,362
| -10% | -$182K | ﹤0.01% | 2068 |
|
|
2023
Q4 | $1.85M | Sell |
309,053
-76,729
| -20% | -$445K | ﹤0.01% | 1988 |
|
|
2023
Q3 | $2.73M | Buy |
385,782
+21,217
| +6% | +$152K | ﹤0.01% | 1756 |
|
|
2023
Q2 | $2.57M | Buy |
364,565
+191,180
| +110% | +$1.53M | ﹤0.01% | 1806 |
|
|
2023
Q1 | $1.45M | Buy |
173,385
+8,517
| +5% | +$82K | ﹤0.01% | 2022 |
|
|
2022
Q4 | $1.89M | Buy |
164,868
+1,415
| +0.9% | +$17.6K | ﹤0.01% | 1911 |
|
|
2022
Q3 | $2.06M | Sell |
163,453
-23,484
| -13% | -$302K | ﹤0.01% | 1844 |
|
|
2022
Q2 | $1.98M | Buy |
186,937
+3,490
| +2% | +$36K | ﹤0.01% | 1894 |
|
|
2022
Q1 | $2.98M | Buy |
183,447
+25,885
| +16% | +$415K | ﹤0.01% | 1796 |
|
|
2021
Q4 | $2.18M | Buy |
157,562
+15
| +0% | +$199 | ﹤0.01% | 1994 |
|
|
2021
Q3 | $2.26M | Buy |
157,547
+111,484
| +242% | +$1.76M | ﹤0.01% | 1967 |
|
|
2021
Q2 | $728K | Sell |
46,063
-3,509
| -7% | -$47.7K | ﹤0.01% | 2262 |
|
|
2021
Q1 | $504K | Sell |
49,572
-2,011
| -4% | -$20.7K | ﹤0.01% | 2303 |
|
|
2020
Q4 | $384K | Buy |
51,583
+14,714
| +40% | +$75.9K | ﹤0.01% | 2307 |
|
|
2020
Q3 | $126K | Sell |
36,869
-4,052
| -10% | -$17.4K | ﹤0.01% | 2431 |
|
|
2020
Q2 | $195K | Sell |
40,921
-406
| -1% | -$1.62K | ﹤0.01% | 2367 |
|
|
2020
Q1 | $83K | Buy |
41,327
+2,602
| +7% | +$7.16K | ﹤0.01% | 2464 |
|
|
2019
Q4 | $134K | Buy |
38,725
+10,143
| +35% | +$25.5K | ﹤0.01% | 2505 |
|
|
2019
Q3 | $82K | Buy |
28,582
+7,057
| +33% | +$22K | ﹤0.01% | 2583 |
|
|
2019
Q2 | $82K | Buy |
21,525
+2,210
| +11% | +$13.3K | ﹤0.01% | 2595 |
|
|
2019
Q1 | $157K | Hold |
19,315
| – | – | ﹤0.01% | 2376 |
|
|
2018
Q4 | $156K | Buy |
19,315
+2,453
| +15% | +$19.1K | ﹤0.01% | 2357 |
|
|
2018
Q3 | $129K | Buy |
16,862
+1,132
| +7% | +$7.6K | ﹤0.01% | 2442 |
|
|
2018
Q2 | $90K | Sell |
15,730
-2,119
| -12% | -$11.7K | ﹤0.01% | 2531 |
|
|
2018
Q1 | $85K | Sell |
17,849
-6,416
| -26% | -$33K | ﹤0.01% | 2522 |
|
|
2017
Q4 | $120K | Buy |
24,265
+2,712
| +13% | +$13.1K | ﹤0.01% | 2497 |
|
|
2017
Q3 | $113K | Buy |
21,553
+3,207
| +17% | +$16.4K | ﹤0.01% | 2575 |
|
|
2017
Q2 | $102K | Buy |
18,346
+860
| +5% | +$5.24K | ﹤0.01% | 2593 |
|
|
2017
Q1 | $146K | Sell |
17,486
-241
| -1% | -$1.68K | ﹤0.01% | 2379 |
|
|
2016
Q4 | $113K | Buy |
17,727
+6,821
| +63% | +$35.5K | ﹤0.01% | 2487 |
|
|
2016
Q3 | $48K | Hold |
10,906
| – | – | ﹤0.01% | 2534 |
|
|
2016
Q2 | $31K | Hold |
10,906
| – | – | ﹤0.01% | 2714 |
|
|
2016
Q1 | $30K | Hold |
10,906
| – | – | ﹤0.01% | 2588 |
|
|
2015
Q4 | $112K | Hold |
10,906
| – | – | ﹤0.01% | 2003 |
|
|
2015
Q3 | $123K | Hold |
10,906
| – | – | ﹤0.01% | 1917 |
|
|
2015
Q2 | $170K | Hold |
10,906
| – | – | ﹤0.01% | 1815 |
|
|
2015
Q1 | $97K | Hold |
10,906
| – | – | ﹤0.01% | 2061 |
|
|
2014
Q4 | $133K | Hold |
10,906
| – | – | ﹤0.01% | 1791 |
|
|
2014
Q3 | $110K | Buy |
+10,906
| New | +$134K | ﹤0.01% | 1826 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC